IP6 (Inositol Hexaphosphate, Phytate) and blood sugar

What 2 graded rows on ip6 (inositol hexaphosphate, phytate) agree on for blood sugar, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the IP6 (Inositol Hexaphosphate, Phytate) page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the IP6 (Inositol Hexaphosphate, Phytate) page, with its PubMed record.

Supplement

IP6 (Inositol Hexaphosphate, Phytate) Choose another

2 rows · 72 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade D, is a crossover trial of 39 people (2023) and found an improvement.

The rows run from 33 to 39 people, published from 2018 to 2023: 2 single studies.

2 improved

Grade DAdiponectin and inflammatory markers in type 2 diabetes · Improved
Crossover RCT · n 39 · 2023 · Adults with type 2 diabetes (Spain)
Not stated in the abstract · 3 months per period
Adiponectin was higher and HbA1c lower after the IP6 period; TNF-alpha, IL-6 and IL-1beta did not differ.
Row on the IP6 (Inositol Hexaphosphate, Phytate) page · PubMed 36854678 (opens PubMed)
Grade DHbA1c and advanced glycation end-products in type 2 diabetes · Improved
Crossover RCT · n 33 · 2018 · Adults with type 2 diabetes (Spain)
380 mg capsule three times daily with meals (full text) · 12 weeks per period, 12-week washout
Circulating AGEs and HbA1c were lower after the IP6 period than the non-IP6 period; iron and transferrin did not differ after adjustment.
Row on the IP6 (Inositol Hexaphosphate, Phytate) page · PubMed 29941991 (opens PubMed)